Literature DB >> 8418064

A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections.

R Tolle1, K Früh, O Doumbo, O Koita, M N'Diaye, A Fischer, K Dietz, H Bujard.   

Abstract

The human humoral immune response to the Plasmodium falciparum merozoite surface antigen gp190 was analyzed to determine the rate of reinfection by the parasite and the ability to control parasite density. The prospective study was carried out in a West African village where malaria is hyperendemic. No correlation between the antibody titers and protection against infection was observed within the group of children. Positive and negative associations of antibody specificities with protection against and/or control of parasitemia were, however, found for adolescents and adults, respectively. Thus, in adolescents, the presence of antibodies to gp190 fragment M6 correlates with a 50% reduced risk of P. falciparum infection and an increased ability to control parasitemia, whereas in adults, the humoral response to some of the polymorphic regions of gp190 associates with an increased risk of infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418064      PMCID: PMC302685          DOI: 10.1128/iai.61.1.40-47.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection.

Authors:  K Marsh; L Otoo; R J Hayes; D C Carson; B M Greenwood
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 May-Jun       Impact factor: 2.184

2.  A protective monoclonal antibody recognizes a linear epitope in the precursor to the major merozoite antigens of Plasmodium chabaudi adami.

Authors:  A M Lew; C J Langford; R F Anders; D J Kemp; A Saul; C Fardoulys; M Geysen; M Sheppard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Natural antibodies against three distinct and defined antigens of Plasmodium falciparum in residents of a mesoendemic area in Gabon.

Authors:  C Chizzolini; A Dupont; J P Akue; M H Kaufmann; A S Verdini; A Pessi; G Del Giudice
Journal:  Am J Trop Med Hyg       Date:  1988-08       Impact factor: 2.345

4.  Third form of the precursor to the major merozoite surface antigens of Plasmodium falciparum.

Authors:  M G Peterson; R L Coppel; M B Moloney; D J Kemp
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

5.  Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes.

Authors:  J A Lyon; A W Thomas; T Hall; J D Chulay
Journal:  Mol Biochem Parasitol       Date:  1989-08       Impact factor: 1.759

6.  A new tool for the serodiagnosis of acute Plasmodium falciparum malaria in individuals with primary infection.

Authors:  K Früh; H M Müller; H Bujard; A Crisanti
Journal:  J Immunol Methods       Date:  1989-08-15       Impact factor: 2.303

7.  Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites.

Authors:  A A Holder; M J Lockyer; K G Odink; J S Sandhu; V Riveros-Moreno; S C Nicholls; Y Hillman; L S Davey; M L Tizard; R T Schwarz
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

8.  Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum.

Authors:  H M Müller; K Früh; A von Brunn; F Esposito; S Lombardi; A Crisanti; H Bujard
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

9.  Antimalarial immunity in Saimiri monkeys. Immunization with surface components of asexual blood stages.

Authors:  L H Perrin; B Merkli; M Loche; C Chizzolini; J Smart; R Richle
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.

Authors:  H Bouharoun-Tayoun; P Attanath; A Sabchareon; T Chongsuphajaisiddhi; P Druilhe
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  25 in total

1.  Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Johnson; R Leke; L Harun; C Ginsberg; J Ngogang; A Stowers; A Saul; I A Quakyi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Assessment of the humoral immune response against Plasmodium falciparum rhoptry-associated proteins 1 and 2.

Authors:  A Stowers; D Taylor; N Prescott; Q Cheng; J Cooper; A Saul
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

3.  Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria.

Authors:  I S Soares; G Levitus; J M Souza; H A Del Portillo; M M Rodrigues
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

4.  Allelic diversity and antibody recognition of Plasmodium falciparum merozoite surface protein 1 during hypoendemic malaria transmission in the Brazilian amazon region.

Authors:  L A Da Silveira; M L Dorta; E A Kimura; A M Katzin; F Kawamoto; K Tanabe; M U Ferreira
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1.

Authors:  Armead H Johnson; Rose G F Leke; Nancy R Mendell; Dewon Shon; Young Ju Suh; Dennis Bomba-Nkolo; Viviane Tchinda; Samuel Kouontchou; Lucy W Thuita; Anne Marie van der Wel; Alan Thomas; Anthony Stowers; Allan Saul; Ainong Zhou; Diane W Taylor; Isabella A Quakyi
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

6.  Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum.

Authors:  E Scarselli; R Tolle; O Koita; M Diallo; H M Müller; K Früh; O Doumbo; A Crisanti; H Bujard
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Cellular responses to modified Plasmodium falciparum MSP119 antigens in individuals previously exposed to natural malaria infection.

Authors:  Christian M F Okafor; Chiaka I Anumudu; Yusuf O Omosun; Chairat Uthaipibull; Idowu Ayede; Henrietta O Awobode; Alex B Odaibo; Jean Langhorne; Anthony A Holder; Roseangela I Nwuba; Marita Troye-Blomberg
Journal:  Malar J       Date:  2009-11-23       Impact factor: 2.979

Review 8.  The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.

Authors:  Freya J I Fowkes; Jack S Richards; Julie A Simpson; James G Beeson
Journal:  PLoS Med       Date:  2010-01-19       Impact factor: 11.069

9.  Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting.

Authors:  Nitchakarn Noranate; Franck Prugnolle; Hélène Jouin; Adama Tall; Laurence Marrama; Cheikh Sokhna; Marie-Thérèse Ekala; Micheline Guillotte; Emmanuel Bischoff; Christiane Bouchier; Jintana Patarapotikul; Jun Ohashi; Jean-François Trape; Christophe Rogier; Odile Mercereau-Puijalon
Journal:  BMC Microbiol       Date:  2009-10-15       Impact factor: 3.605

10.  Shift in epitope dominance of IgM and IgG responses to Plasmodium falciparum MSP1 block 4.

Authors:  Sandra P Chang; Alexander K K Kayatani; Zilka I Terrientes; Socrates Herrera; Rose G F Leke; Diane W Taylor
Journal:  Malar J       Date:  2010-01-13       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.